Muscle & Performance
Growth hormone secretagogues and anabolic-support peptides studied for lean mass and performance. 40 profiles, 9 sourceable from N1 Aminos.
CJC-1295 (No DAC)
No DAC
CJC-1295 without DAC, also called Mod GRF 1-29, is a refined growth hormone-releasing hormone analog that creates natural-feeling GH pulses to boost muscle repair, fat metabolism, and youthful vitality without constant elevation. Unlike the DAC version that lingers for days, no-DAC provides short 30-60 minute bursts mimicking your pituitary’s natural response during deep sleep or exercise, preserving sensitivity and avoiding receptor fatigue.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC), Ipamorelin
No DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) and Ipamorelin form a clean, beginner-friendly GH duo that gently amplifies your natural growth hormone pulses for muscle growth, fat loss, and recovery without the hunger or side effects of stronger secretagogues. CJC-1295 mimics the brain’s GH-releasing hormone for short, physiologic bursts, while Ipamorelin selectively activates GH pathways without raising cortisol, prolactin, or appetite—making it one of the safest options.
- Route
- Subcutaneous
- Dose
- 333 mcg – 2 mg
- Cycle
- 12–16 weeks
BPC-157, TB-500
The peptide blend of BPC-157 (Body Protection Compound) and TB-500 (a synthetic version of Thymosin Beta-4) is a popular combination in regenerative medicine, often referred to as the “Wolverine Stack” due to its potential to accelerate tissue repair. BPC-157 is a pentadecapeptide originally derived from human gastric juice, known for its “cytoprotective” properties and its ability to upregulate growth hormone receptors in fibroblasts.
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
IGF-1 LR3
IGF-1 LR3 is a long-acting variant of insulin-like growth factor 1 designed to remain active in your bloodstream for hours rather than minutes, delivering sustained muscle-building, fat-burning, and anti-aging effects. The “LR3” refers to a structural modification that extends its half-life dramatically, allowing one injection to provide extended anabolic signaling throughout your body.
- Route
- Subcutaneous
- Dose
- 100 mcg
- Cycle
- 4–8 weeks
MOTS-c
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a mitochondrial-derived hormone peptide discovered to be released during exercise that awakens your cells’ power generators to burn fuel more efficiently, build muscle faster, and resist aging at the metabolic level. This 16-amino acid “mitokine” transfers to your cell nucleus during metabolic stress to activate protective genes, simultaneously boosting glucose uptake into muscles via AMPK activation, reducing inflammation, and protecting your heart and brain from oxidative damage—essentially molecular exercise in a syringe.
- Route
- Subcutaneous
- Dose
- 200 mcg – 1 mg
- Cycle
- 8–12 weeks
TB-500 (Thymosin Beta-4)
Thymosin Beta-4
TB-500, the synthetic 43-amino-acid version of Thymosin Beta-4, accelerates tissue repair by upregulating actin polymerization, promoting cell migration, angiogenesis, and anti-inflammatory cytokine profiles—achieving 61% wound re-epithelialization by day 7 versus saline controls while preventing scar formation through collagen organization. It sequesters actin monomers to facilitate cytoskeletal remodeling essential for endothelial cell movement, fibroblast proliferation, and myocyte regeneration across skin, muscle, tendon, ligament, heart, and cornea.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 8–12 weeks
Ipamorelin
Ipamorelin is a clean, selective growth hormone secretagogue that gently stimulates your pituitary to release GH in natural, pulsatile patterns that preserve your body’s feedback loops and avoid receptor fatigue. Unlike aggressive peptides like GHRP-2 that trigger hunger and multiple hormones, Ipamorelin specifically targets GH release without stimulating appetite, prolactin, or cortisol—making it ideal for those seeking muscle and fat-loss gains without side effects.
- Route
- Subcutaneous
- Dose
- 100 mcg – 250 mcg
- Cycle
- 8–12 weeks
Sermorelin
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that naturally stimulates your pituitary gland to produce and release its own growth hormone rather than supplying synthetic GH directly—preserving your endocrine system’s feedback loops and natural hormone rhythms for sustainable, side-effect-minimal hormone optimization. Clinical research shows 82-107% increases in GH levels sustained for approximately 2 hours, translating to 28% IGF-1 elevation supporting muscle growth, fat loss, collagen synthesis, and comprehensive anabolic benefits with a 16-week treatment period.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 3–6 months
Tesamorelin
Tesamorelin acetate · GHRH(1-44)
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary to release its own growth hormone, achieving FDA-approved clinical efficacy for HIV-associated lipodystrophy with 15-20% visceral adipose tissue (VAT) reduction over 26 weeks—preferentially targeting dangerous abdominal fat while preserving subcutaneous fat and lean muscle mass, a metabolic selectivity unique among weight loss therapies.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 12–26 weeks
CJC-1295 (No DAC), GHRP-2
No DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) and GHRP-2 together form a synergistic growth hormone combo that naturally boosts your body’s muscle-building, fat-burning, and recovery superpowers. CJC-1295 without DAC mimics your brain’s natural growth hormone-releasing hormone, creating quick pulses of growth hormone release that mirror your body’s youthful rhythm (the natural surge during deep sleep).
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–16 weeks
CJC-1295 (No DAC), GHRP-6
No DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) paired with GHRP-6 creates a powerful dual-action growth hormone stimulation system that boosts muscle growth, burns fat, accelerates healing, and provides surprising cardiac and systemic protection benefits. Like the GHRP-2 version, this combination works through complementary pathways: CJC-1295 triggers pulsatile growth hormone release mimicking your body’s natural rhythms, while GHRP-6 raises the baseline level of GH and activates additional protective pathways beyond just hormone elevation.
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC), Ipamorelin, GHRP-2
No DAC · CJC-1295 (No DAC)
This triple peptide blend—CJC-1295 (No DAC), Ipamorelin, and GHRP-2—represents a premium growth hormone optimizer that multiplies natural GH release through three complementary pathways for superior muscle building, fat metabolism, and recovery. CJC-1295 triggers the main GH pulse like your body’s sleep signal, Ipamorelin provides clean, selective GH stimulation without hunger or prolactin spikes, and GHRP-2 adds extra amplification for even higher peaks.
- Route
- Subcutaneous
- Dose
- 100 mcg – 600 mcg
- Cycle
- 12–16 weeks
GHRP-2
GHRP-2 is a powerful growth hormone secretagogue that mimics ghrelin (your “hunger hormone”) to stimulate dramatic GH release while also genuinely increasing appetite and food intake—useful for people with wasting, poor appetite, or recovery needs. It activates the same receptor as ghrelin, causing pituitary cells to release stored GH and promote new GH synthesis, creating GH spikes up to 36-fold higher than normal.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
GHRP-6
GHRP-6 is another potent ghrelin mimetic that powerfully boosts growth hormone release while offering unique tissue protection and healing benefits beyond typical GH peptides. Like GHRP-2, it triggers massive GH spikes (up to 10-60 fold baseline), but GHRP-6 additionally activates CD36 receptors that reduce cell death from stress and damage—essentially protecting your organs and tissues from harm.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
HGH Fragment, CJC-1295 (No DAC), Ipamorelin
No DAC · HGH Fragment 176-191
This triple stack—HGH Fragment 176-191 for targeted fat loss, CJC-1295 (No DAC) for natural GH pulses, and Ipamorelin for clean amplification—creates comprehensive body recomposition by burning stubborn fat while preserving and building lean muscle. The Fragment mimics growth hormone’s fat-mobilizing region, accelerating lipolysis especially in the abdomen without affecting blood sugar.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 8–12 weeks
HGH Fragment, Modified GRF, Ipamorelin
HGH Fragment 176-191 · hGH Frag 176-191
HGH Fragment 176-191 combined with Modified GRF (CJC-1295 No DAC) and Ipamorelin creates a triple-action body recomposition system that burns fat aggressively while preserving muscle and amplifying growth hormone at multiple levels. The Fragment targets the specific fat-burning region of growth hormone without affecting blood sugar or hormones, Modified GRF triggers natural pulsatile GH release mimicking your body’s youthful pattern, and Ipamorelin amplifies those pulses cleanly.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks
MK-677
MK-677 (Ibutamoren) is an oral growth hormone secretagogue that mimics ghrelin to continuously elevate GH and IGF-1 levels for 24 hours daily, delivering sustained anabolic effects without injections or pituitary suppression. Unlike peptides requiring multiple doses, MK-677 provides steady-state hormone elevation, improving nitrogen retention, deep sleep quality, and connective tissue strength for comprehensive body recomposition and anti-aging.
- Route
- Oral
- Dose
- 12.5 mg – 50 mg
- Cycle
- 12–16 weeks; monitoring of fasting blood glucose is standard
Mod GRF, GHRP-2
Mod GRF (1-29) · Modified GRF (1-29)
The Mod GRF (1-29)/GHRP-2 blend combines sustained GH pulse amplification with powerful secretagogue action, producing synergistic 50-fold GH spikes that dramatically exceed either peptide alone for superior muscle growth, fat loss, and recovery. Mod GRF provides the prolonged receptor stimulation mimicking natural GHRH, while GHRP-2 aggressively amplifies pituitary response via ghrelin mimicry, creating the most potent injectable GH elevation available.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–16 weeks
Mod GRF, GHRP-6
Mod GRF (1-29) · Modified GRF (1-29)
Mod GRF/GHRP-6 synergistically unleashes massive GH pulses through complementary mechanisms—Mod GRF extending signal duration while GHRP-6 provides intense ghrelin-mediated spikes—ideal for aggressive muscle building and appetite enhancement during bulking phases. The combination overcomes individual limitations, delivering prolonged, high-amplitude GH release mimicking peak youthful physiology.
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 8–12 weeks
Mod GRF, Ipamorelin
The Mod GRF/Ipamorelin combination represents the cleanest, most physiologic growth hormone secretagogue stack available, delivering sustained GH elevation without appetite stimulation, cortisol spike, or receptor desensitization—ideal for fat loss, recovery, and longevity. Mod GRF (CJC-1295 No DAC) provides prolonged GHRH stimulation extending GH pulse duration, while Ipamorelin gently amplifies the pituitary’s release via ghrelin mimicry without the side effects of aggressive secretagogues, creating a synergistic rhythm mimicking youthful sleep-phase GH secretion.
- Route
- Subcutaneous
- Dose
- 167 mcg – 333 mcg
- Cycle
- 12–16 weeks
Mod GRF, Ipamorelin, GHRP-2
The triple blend of Mod GRF, Ipamorelin, and GHRP-2 creates ultimate GH pulse architecture—sustained amplitude from Mod GRF, clean selectivity from Ipamorelin, and raw power from GHRP-2—for comprehensive body recomposition without cortisol disruption or excessive hunger. Multi-pathway activation yields 10x+ GH elevation with metabolic optimization.
- Route
- Subcutaneous
- Dose
- 300 mcg – 450 mcg
- Cycle
- 12–16 weeks
Sermorelin, GHRP-2
Sermorelin combined with GHRP-2 creates a dual-mechanism growth hormone amplification stack where Sermorelin acts as the “on switch” via GHRH receptor activation to trigger GH production and release, while GHRP-2 acts as the “volume knob” via ghrelin receptor agonism to amplify the pituitary’s GH response and frequency—together producing 10-20 fold higher GH elevation than either peptide alone.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–16 weeks
Sermorelin, GHRP-6
Sermorelin paired with GHRP-6 delivers sustained GH elevation alongside GHRP-6’s unique appetite-stimulating and cardioprotective properties, making it ideal for bulking phases where caloric surplus is critical for muscle gain. Sermorelin triggers GH production via natural GHRH pathways while GHRP-6 amplifies release and provides appetite enhancement and additional anti-inflammatory benefits promoting rapid tissue repair.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 8–12 weeks
Sermorelin, GHRP-6, GHRP-2
The triple-peptide stack of Sermorelin, GHRP-6, and GHRP-2 combines all three complementary growth hormone pathways simultaneously—Sermorelin triggering production via GHRH, GHRP-6 amplifying release plus appetite and anti-inflammatory support, and GHRP-2 providing additional secretagogue power and muscle-structural enhancement. While individual addition doesn’t yield proportionally greater GH spikes than dual stacks, the combination provides multi-system benefits spanning muscle growth, fat loss, appetite support, inflammation reduction, cardiovascular protection, and metabolic optimization.
- Route
- Subcutaneous
- Dose
- 100 mcg – 600 mcg
- Cycle
- 12–16 weeks
Sermorelin, Ipamorelin
Sermorelin combined with Ipamorelin represents the cleanest, most physiologic growth hormone stack, where Sermorelin triggers immediate GH response via GHRH pathways (11-12 minute half-life for rapid effect) while Ipamorelin extends and sustains GH elevation via ghrelin agonism (2-hour half-life for sustained action). Sermorelin may increase GH 82-107% while Ipamorelin contributes additional sustained elevation and potentially adds 1000%+ amplification at its peak, combining immediate onset with sustained duration for complete GH curve optimization.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–24 weeks
Tesamorelin, CJC-1295 (No DAC), Ipamorelin
No DAC
This triple stack synergistically maximizes visceral fat reduction through Tesamorelin’s targeted abdominal lipolysis (15% waist circumference reduction in HIV lipodystrophy), CJC-1295’s sustained GH pulsatility (3-5x baseline elevation over 6-8 hours), and Ipamorelin’s clean GH amplification without cortisol/prolactin spikes—achieving superior IGF-1 increases (up to 200%) and metabolic optimization versus dual therapies. Tesamorelin selectively mobilizes trunk fat via hypothalamic GH axis stimulation, complemented by CJC-1295’s half-life extension and Ipamorelin’s pituitary synergy.
- Route
- Subcutaneous
- Dose
- 100 mcg – 1 mg
- Cycle
- 12–26 weeks
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
5-Amino-1MQ is a special tiny molecule that acts like a helper in your body, targeting fat storage and energy use. Imagine it as a smart switch that turns down an enzyme called NNMT, which normally slows your metabolism and helps fat cells grow.
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
AICAR
Acadesine · AICA-Riboside
AICAR is an exercise-mimicking peptide that tricks your body into workout mode without moving a muscle. It activates a pathway called AMPK, which ramps up fat burning, boosts endurance, and improves heart health—like a molecular personal trainer.
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
Follistatin 315
Research Goal: Assessing the inhibition of TGF-β ligands, specifically myostatin and activin A, for muscle growth acceleration.
- Route
- Subcutaneous
- Dose
- 100 mcg
- Cycle
- 10–30 days, followed by a significant washout period (4–8 weeks)
Follistatin 344
Research Goal: Evaluate the suppression of myostatin (GDF-8) to facilitate rapid skeletal muscle cell proliferation and lean mass accrual.
- Route
- Subcutaneous
- Dose
- 100 mcg
- Cycle
- 10–20 days per cycle, followed by a 4-week washout
IGF-1 DES
IGF-1 DES is a modified version of insulin-like growth factor 1 with enhanced muscle-building and fat-loss properties due to its longer systemic activity compared to natural IGF-1, which only works for minutes. The DES modification preserves all anabolic effects while improving stability, allowing it to circulate longer and deliver more cumulative growth signals to muscle and fat cells.
- Route
- Subcutaneous
- Dose
- 25 mcg – 100 mcg
- Cycle
- 4 weeks on, followed by 4 weeks off
MGF (Mechano Growth Factor)
Mechano Growth Factor
Mechano Growth Factor (MGF) is a splice variant of IGF-1 expressed specifically in response to mechanical stress like weight training, activating muscle satellite stem cells to repair micro-tears and drive hypertrophy beyond natural limits. Released post-workout from damaged muscle fibers, it recruits stem cells to fuse with existing myofibrils, adding nuclei for greater protein synthesis capacity and rapid tissue remodeling—explaining why heavy resistance training builds muscle faster than any other stimulus.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
PEG MGF
Research Goal: Investigating the induction of muscle hyperplasia and the repair of damaged skeletal muscle tissue via the E-domain of IGF-1.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 4–6 weeks
SLU-PP-332
SLU-PP-332 is an oral estrogen-related receptor (ERR) agonist that mimics exercise at the molecular level, activating the same metabolic pathways as 30 minutes of intense cardio without requiring physical exertion—enabling metabolic transformation through gene expression alone. Preclinical studies show it reduces fat mass by 12% in diet-induced obesity models while preventing new fat gain (versus 5g gain in controls), dramatically improves glucose tolerance and insulin sensitivity, reverses hepatic steatosis (fatty liver disease), and reduces inflammatory markers in liver and adipose tissue—all without increasing physical activity or changing diet.
- Route
- Subcutaneous
- Dose
- 1.25 mg
- Cycle
- Research cycles typically span 4–8 weeks
CJC-1295 (no DAC), Hexarelin
no DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) combined with Hexarelin creates a high-potency growth hormone stack that delivers powerful muscle growth, fat loss, and recovery benefits through synergistic hormone pulses. CJC-1295 without DAC acts like a natural signal from your brain to release growth hormone in short, strong bursts that mimic your body’s youthful sleep-time surges.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 4–6 weeks (shorter cycles prevent receptor desensitization)
GHRH
GHRH, or Growth Hormone-Releasing Hormone, is your brain’s master signal that tells your pituitary gland to make and release growth hormone in healthy, pulsatile patterns that mirror youthful sleep cycles. Produced naturally in a small brain region called the hypothalamus, it controls far more than just muscle growth—GHRH also regulates metabolism, bone density, immune function, sleep quality, and cognitive sharpness.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12 weeks
Hexarelin
Research Goal: Analyzing peak GH pulse amplitude and the protective effects of Hexarelin on cardiac myocytes via CD36 receptors.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 4 weeks on, followed by a 4-week washout to maintain pituitary sensitivity
Mod GRF, Hexarelin
Mod GRF/Hexarelin represents peak GH secretagogue potency, combining sustained GHRH agonism with Hexarelin’s extreme receptor affinity for explosive, sustained GH elevation supporting maximal hypertrophy and strength. The blend produces among the highest recorded GH peaks, with neuroprotective and cardiovascular benefits from Hexarelin’s unique profile.
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 4 weeks on, followed by a 4-week washout period
Tesamorelin, Ipamorelin
Tesamorelin paired with Ipamorelin targets visceral fat obliteration through Tesamorelin’s specific trunk adipose reduction (1.3kg fat mass loss over 26 weeks) amplified by Ipamorelin’s selective GH release (no appetite/cortisol elevation), creating sustained IGF-1 elevation for metabolic and anabolic benefits without DAC-related prolongation risks. Tesamorelin’s FDA-approved HIV lipodystrophy efficacy translates to general visceral fat targeting, enhanced by Ipamorelin’s clean secretagogue profile.
- Route
- Subcutaneous
- Dose
- 1 mg
- Cycle
- 12–26 weeks
TRH Thyrotropin (Protirelin)
Protirelin
Research Goal: Analyzing the acute thyroid-stimulating hormone (TSH) response and the neuroprotective potential of TRH in central nervous system research.
- Route
- Subcutaneous
- Dose
- 200 mcg – 1 mg
- Cycle
- Short pulses only; chronic use can desensitize TSH receptors
Research compounds with a paper trail.
N1 Aminos tests every batch at an independent lab, ships tracked in 3–5 days, and publishes certificates of analysis on request.
Shop N1 Aminos →Code DOSING15 · 15% off first order
Where to trackNever miss a dose or a cycle end.
StackTracker turns any protocol on this site into a daily brief with one-tap logging, half-life graphs and lab-result tracking.
Start a free trial →